Staff View: Breakthrough business models

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.

Saved in:

Bibliographic Details
:	Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
TeilnehmendeR:	Wizemann, Theresa M. Robinson, Sally. Giffin, Robert B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm)
Year of Publication:	2009
Language:	English
Online Access:	https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378464
Physical Description:	149 p. :; ill.
Tags:	Add Tag No Tags, Be the first to tag this record!

id	5003378464
ctrlnum	(MiAaPQ)5003378464 (Au-PeEL)EBL3378464 (CaPaEBR)ebr10286191 (CaONFJC)MIL208355 (OCoLC)923280041
collection	bib_alma
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01711nam a2200397 a 4500</leader><controlfield tag="001">5003378464</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d \| </controlfield><controlfield tag="007">cr cn\|\|\|\|\|\|\|\|\|</controlfield><controlfield tag="008">090925s2009 dcua sb 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309120883</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309120888</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003378464</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3378464</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10286191</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL208355</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)923280041</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA401.A3</subfield><subfield code="b">B74 2009</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Breakthrough business models</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">drug development for rare and neglected diseases and individualized therapies : workshop summary /</subfield><subfield code="c">Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">2009.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">149 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 104-105).</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Orphan drugs</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wizemann, Theresa M.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robinson, Sally.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giffin, Robert B.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378464</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>
record_format	marc
spelling	Breakthrough business models [electronic resource] : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, 2009. 149 p. : ill. Includes bibliographical references (p. 104-105). Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Orphan drugs Government policy United States. Pharmaceutical policy United States. Drugs Design United States. Electronic books. Wizemann, Theresa M. Robinson, Sally. Giffin, Robert B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378464 Click to View
language	English
format	Electronic eBook
author2	Wizemann, Theresa M. Robinson, Sally. Giffin, Robert B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm)
author_facet	Wizemann, Theresa M. Robinson, Sally. Giffin, Robert B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm) Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm)
author2_variant	t m w tm tmw s r sr r b g rb rbg
author2_role	TeilnehmendeR TeilnehmendeR TeilnehmendeR TeilnehmendeR TeilnehmendeR
author_corporate	Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ProQuest (Firm)
author_sort	Wizemann, Theresa M.
title	Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
spellingShingle	Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
title_sub	drug development for rare and neglected diseases and individualized therapies : workshop summary /
title_full	Breakthrough business models [electronic resource] : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
title_fullStr	Breakthrough business models [electronic resource] : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
title_full_unstemmed	Breakthrough business models [electronic resource] : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
title_auth	Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
title_new	Breakthrough business models
title_sort	breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
publisher	National Academies Press,
publishDate	2009
physical	149 p. : ill.
callnumber-first	R - Medicine
callnumber-subject	RA - Public Medicine
callnumber-label	RA401
callnumber-sort	RA 3401 A3 B74 42009
genre	Electronic books.
genre_facet	Electronic books.
geographic_facet	United States.
url	https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378464
illustrated	Illustrated
oclc_num	923280041
work_keys_str_mv	AT wizemanntheresam breakthroughbusinessmodelsdrugdevelopmentforrareandneglecteddiseasesandindividualizedtherapiesworkshopsummary AT robinsonsally breakthroughbusinessmodelsdrugdevelopmentforrareandneglecteddiseasesandindividualizedtherapiesworkshopsummary AT giffinrobertb breakthroughbusinessmodelsdrugdevelopmentforrareandneglecteddiseasesandindividualizedtherapiesworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation breakthroughbusinessmodelsdrugdevelopmentforrareandneglecteddiseasesandindividualizedtherapiesworkshopsummary AT proquestfirm breakthroughbusinessmodelsdrugdevelopmentforrareandneglecteddiseasesandindividualizedtherapiesworkshopsummary
status_str	n
ids_txt_mv	(MiAaPQ)5003378464 (Au-PeEL)EBL3378464 (CaPaEBR)ebr10286191 (CaONFJC)MIL208355 (OCoLC)923280041
is_hierarchy_title	Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
author2_original_writing_str_mv	noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField
_version_	1792330865455398912

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.

Similar Items